Endothelium-derived markers and antioxidant status in the blood of obstructive sleep apnea males

European Journal of Medical Research

Volumn 14, Issue SUPPL.4, 2009, Pages 49-52

  Cofta, S ^a   Wysocka, E ^a   Michalak, S ^a   Piorunek, T ^a   Batura Gabryel, H ^a   Torlinski, L ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

E selectin; endothelium; obstructive sleep apnea; total antioxidant status

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD; HUMAN; MALE; METABOLISM; MIDDLE AGED; SLEEP APNEA SYNDROME;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; E-SELECTIN; HUMANS; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE;

EID: 77955489888     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-14-S4-49     Document Type: Article

References (25)

1. Sleep-disordered breathing and cardiovascular disease: cross sectional results of the Sleep Heart Health Study. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O'Connor GT, Boland LL, Schwartz JE, Samet JM, Am J Respir Crit Care Med 2001 163 1 19 25 11208620 (Pubitemid 32095247)
2. Increased incidence of cardiovascular disease in the middleaged men with obstructive sleep apnea: a 7-year follow up. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J, Am J Respir Crit Care Med 2002 166 2 159 65 10.1164/rccm.2105124 12119227 (Pubitemid 34765451)
3. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Martin JM, Carrizo SJ, Vicente E, Agusti AG, Lancet 2005 365 9464 1046 53 19-25 15781100 (Pubitemid 40386782)
4. Association of sleep-disordered breathing and the occurrence of stroke. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD, Am J Respir Crit Care Med 2005 172 11 1447 51 10.1164/rccm.200505-702OC 16141444 (Pubitemid 43069819)
5. Nocturnal hypoxia is associated with silent cerebrovascular disease in a high-risk Japanese community- dwelling population. Eguchi K, Kario K, Hoshide S, Ishikawa J, Morinari M, Shimada K, Am J Hypertens 2005 18 11 1489 95 10.1016/j.amjhyper.2005.05.032 16280287 (Pubitemid 41566681)
6. Sleep and cardiovascular disease: present and future. Javaheri S, Principles and practice of Sleep Medicine Philadelphia, PA; Elservier, Krygier MH, Roth T, Dement WC, 4 2005 1157 1160
7. Inflammation and atherosclerosis. Kaperonis EA, Liapis CD, Kakisis JD, Dimitroulis D, Papavassiliou, Eur J Vasc Endovasc Surg 2006 31 4 386 93 10.1016/j.ejvs.2005.11.001 16359887
8. Monocyte recruitment and foam cell formation in atherosclerosis. Bobryshev YV, Micron 2006 37 3 208 22 10.1016/j.micron.2005.10.007 16360317 (Pubitemid 43106595)
9. Adhesion molecules and atherosclerosis. Blankerberg S, Barbaux S, Tiret L, Atherosclerosis 2003 170 2 191 203 10.1016/S0021-9150(03)00097-2 14612198 (Pubitemid 37377790)
10. Endothelial dysfunction: a comprehensive appraisal. Esper RJ, Nordaby RA, Vilarino JO, Paragano A, Cacharron JL, Machado RA, Cardiovasc Diabetol 2006 5 4 10.1186/1475-2840-5-4 16504104
11. Atherothrombosis, inflammation, and diabetes. Biondi-Zoccai GG, Abbate A, Liuzzo G, Biasucci LM, J Am Coll Cardiol 2003 41 7 1071 7 Review 10.1016/S0735-1097(03)00088-3 12679203 (Pubitemid 36384890)
12. Obstructive sleep apnea syndrome-an oxidative stress disorder. Lave L, Sleep Med Rev 2003 7 1 35 51 Review 10.1053/smrv.2002.0261 12586529 (Pubitemid 36188305)
13. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. Jordan W, Cohrs S, Degner D, Meier A, Rodenbeck A, Mayer G, Pilz J, Ruther E, Kornhuber J, Bleich S, J Neural Transm 2006 113 2 239 54 10.1007/s00702-005-0316-2 15959848 (Pubitemid 43121759)
14. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F, Am J Respir Crit Care Med 2002 165 1 67 70 11779732 (Pubitemid 34053359)
15. New markers of inflammation and endothelial cell activation: Part I. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S, Circulation 2003 108 16 1917 23 10.1161/01.CIR.0000089190.95415.9F 14568885 (Pubitemid 37296533)
16. Plasma adhesion molecules in children with sleep-disordered breathing. O'Brien LM, Serpero LD, Tauman R, Gozal D, Chest 2006 129 4 947 53 10.1378/chest.129.4.947 16608943
17. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomized controlled trials. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR, Thorax 2004 59 9 777 82 10.1136/thx.2003.018739 15333855 (Pubitemid 39215375)
18. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. El-Solh AA, Mador MJ, Sikka P, Dhillon RS, Amsterdam D, Grant BJ, Chest 2002 121 5 1541 7 10.1378/chest.121.5. 1541 12006441 (Pubitemid 34499668)
19. Plasma levels of vascular endothelial markers in obstructive sleep apnea. Zamarrán-Sanz C, Ricoy-Galbaldon J, Gude-Sampedro F, Riveiro-Riveiro A, Arch Med Res 2006 37 4 552 5 10.1016/j.arcmed.2005.10.011 16624658
20. Soluble P-selectin and the risk of future cardiovascular events. Ridker PM, Buring JE, Rifai N, Circulation 2001 103 4 491 5 10.1161/01.CIR.103.4.491 11157711 (Pubitemid 32116231)
21. Silent brain infarction and platelet activation in obstructive sleep apnea. Minoguchi K, Yokoe T, Tazaki T, Minguchi H, Oda N, Tanaka A, Yamamoto M, Ohta S, O'Donnell CP, Adachi M, Am J Respir Crit Care Med 2007 175 6 612 7 10.1164/rccm.200608-1141OC 17341649 (Pubitemid 46438946)
22. Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome. Cofta S, Wysocka E, Piorunek T, Rzymkowska M, Batura-Gabryel H, Torlinski L, J Physiol Pharmacol 2008 59 Suppl 6 183 90 19218642
23. Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. Channon KM, Guzik TJ, J Physiol Pharmacol 2002 53 4 515 24 Review 12512689 (Pubitemid 36014798)
24. Reactive oxygen species in vascular wall. Yung LM, Leung FP, Yao X, Chen ZY, Huang Y, Cardiovasc Hematol Disord Drug Targets 2006 6 1 1 19 Review 10.2174/187152906776092659 16724932 (Pubitemid 43803123)
25. Injuries to the vascular endothelium: vascular wall and endothelial dysfunction. Fisher M, Rev Neurol Dis 2008 5 Suppl 1 4 11 18645570